Trinity Biotech plc (TRIB)

Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	1.55	5.17	3.69	6.58
Cash & Short-Term Investments	1.55	5.17	3.69	6.58
Cash Growth	-70.92%	39.99%	-43.89%	-
Accounts Receivable	10.89	16.07	13.9	15.75
Inventory	20.13	19.37	19.93	22.5
Other Current Assets	0.43	0.52	1.52	1.83
Total Current Assets	33	41.12	39.04	46.67
Net Property, Plant & Equipment	4.31	4.62	1.89	5.68
Other Intangible Assets	55.92	51.34	16.27	35.27
Long-Term Investments	2.76	2.46	-	-
Other Long-Term Assets	0.1	0.19	0.26	0.27
Total Assets	99.63	103.29	59.44	92.1
Accounts Payable	26.49	26.78	12.8	15.38
Current Portion of Long-Term Debt	0.21	0.21	0.21	0.21
Current Portion of Leases	2.3	2.29	1.69	1.68
Other Current Liabilities	2.53	2.82	0.33	0.08
Total Current Liabilities	31.52	32.1	15.04	17.34
Long-Term Debt	99.5	87.79	54.65	58.05
Long-Term Leases	10.55	10.48	10.87	12.27
Other Long-Term Liabilities	7.59	8.11	2.83	6.63
Total Long-Term Liabilities	117.65	106.38	68.35	76.94
Total Liabilities	149.17	138.47	83.38	94.28
Common Stock	4.34	4.19	1.97	1.96
Treasury Stock	-24.92	-24.92	-24.92	-24.92
Additional Paid-in Capital	70.51	70.11	53.33	53.17
Accumulated Other Comprehensive Income	-5.8	-5.44	-5.68	-5.69
Retained Earnings	-93.66	-79.12	-48.64	-26.7
Shareholders' Equity	-49.54	-35.18	-23.95	-2.18
Total Liabilities & Equity	99.63	103.29	59.44	92.1
Total Debt	112.56	100.76	67.43	72.2
Net Cash (Debt)	-111.01	-95.6	-63.74	-65.62
Net Cash Per Share	-7.33	-5.32	-8.33	-9.73
Book Value	-49.54	-35.18	-23.95	-2.18
Book Value Per Share	-3.27	-1.96	-3.13	-0.32
Tangible Book Value	-105.46	-86.52	-40.22	-37.45
Tangible Book Value Per Share	-6.96	-4.82	-5.25	-5.55

Updated Dec 23, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q